How Melanotan II Causes Side Effects

Melanotan II is a non-selective melanocortin agonist, meaning it activates all five melanocortin receptor subtypes (MC1R through MC5R). This broad activity is the fundamental reason it produces a wider range of side effects than more targeted peptides. Each receptor subtype serves different functions in the body, so activating all of them simultaneously produces effects across skin, brain, gut, and cardiovascular systems .

Common Side Effects

Nausea

Nausea is the most commonly reported side effect, particularly during the initial loading phase. It typically occurs 10 to 30 minutes after injection and lasts 30 minutes to 2 hours. The severity is dose-dependent. Many practitioners recommend starting at a low dose (100-250 mcg) and titrating up to reduce nausea severity .

Management strategies include:

• Taking the injection before bed so nausea occurs during sleep
• Starting at a lower dose and increasing gradually
• Taking an over-the-counter anti-nausea medication 30 minutes before injection (with physician approval)
• Eating a small, bland meal before injection

Facial Flushing

A warm, red flush across the face and sometimes the upper body is common shortly after injection. This results from melanocortin-mediated vasodilation and is harmless, though it can be uncomfortable or socially inconvenient. It typically resolves within 30 to 60 minutes.

Spontaneous Erections

Male users frequently report erections occurring 1 to 5 hours after injection. This effect led to the development of bremelanotide (Vyleesi) for sexual dysfunction. While not dangerous, it can be inconvenient and is an important consideration for daytime dosing .

Serious Side Effects and Concerns

Mole and Nevi Changes

This is the most clinically important side effect. Melanotan II stimulates melanocyte activity throughout the body, including in existing moles and nevi. Case reports and observational data have documented darkening of existing moles, appearance of new nevi, and changes in mole shape or size during Melanotan II use .

The concern is that stimulating melanocyte proliferation could theoretically promote the growth of pre-existing atypical cells. While a direct causal link between Melanotan II and melanoma has not been established in controlled studies, several case reports have described melanoma diagnosis in Melanotan II users .

Our recommendation: Any patient using Melanotan II should undergo a baseline dermatological examination before starting and regular skin checks every 3 to 6 months during use. Report any new moles or changes in existing moles to your dermatologist immediately.

Cardiovascular Effects

Melanocortin receptors are expressed in cardiovascular tissue. Some users report transient increases in blood pressure and heart rate after injection. Clinical trial data from early Phase I studies noted mild blood pressure elevations in some subjects .

Patients with pre-existing cardiovascular conditions, uncontrolled hypertension, or heart disease should exercise caution and discuss risks thoroughly with their physician before considering Melanotan II.

Renal Considerations

Isolated case reports have described rhabdomyolysis (muscle breakdown) in individuals using Melanotan II, though these cases often involved confounding factors such as extreme exercise or dehydration . Adequate hydration during use is advisable.

Side Effects Timeline

Who Should Avoid Melanotan II

• History of melanoma or atypical moles: Stimulating melanocyte activity in patients with melanoma history is not recommended.
• Pregnant or breastfeeding women: Insufficient safety data exists for use during pregnancy or lactation.
• Uncontrolled cardiovascular disease: Blood pressure and heart rate effects pose additional risk.
• Severe kidney disease: Limited excretion data; caution advised.
• Children and adolescents: Not studied in pediatric populations.

Frequently Asked Questions

Do Melanotan II side effects go away?

Most acute side effects (nausea, flushing, fatigue) diminish over the first 1 to 2 weeks as your body adjusts. Starting at a low dose and increasing gradually helps minimize initial side effects. Mole changes, however, may persist and require ongoing monitoring.

Is Melanotan II nausea dangerous?

The nausea itself is not dangerous, though it can be quite unpleasant. If nausea is severe or accompanied by vomiting, reduce your dose and discuss management strategies with your physician. Taking the injection before bed is the most effective strategy reported by patients.

Can Melanotan II cause cancer?

There is no definitive evidence that Melanotan II causes cancer. However, its stimulation of melanocyte proliferation raises theoretical concerns, and case reports of melanoma in users have been published. The absence of large controlled studies means this risk cannot be quantified. Regular skin monitoring is essential .

How do I reduce Melanotan II side effects?

Start at the lowest effective dose, inject before bedtime, stay hydrated, and titrate up slowly over 1 to 2 weeks. Most side effects are dose-dependent and improve with time and gradual dosing.